Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 "Infectious" optimism for treatment of hepatocellular carcinoma.

Literature DB >> 23542566

"Infectious" optimism for treatment of hepatocellular carcinoma.

Kenneth K Tanabe¹, E Antonio Chiocca.

Abstract

Entities: Disease

Mesh：

Year: 2013 PMID： 23542566 PMCID： PMC3616522 DOI： 10.1038/mt.2013.47

Source DB: PubMed Journal: Mol Ther ISSN： 1525-0016 Impact factor: 11.454

× No keyword cloud information.

10 in total

Review 1. Hepatocellular carcinoma.

Authors: Hashem B El-Serag
Journal: N Engl J Med Date: 2011-09-22 Impact factor: 91.245

2. Note on the experimental use of rabies vaccine for melanomatosis.

Authors: G T PACK
Journal: AMA Arch Derm Syphilol Date: 1950-11

3. Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck.

Authors: Kevin J Harrington; Mohan Hingorani; Mary Anne Tanay; Jennifer Hickey; Shreerang A Bhide; Peter M Clarke; Louise C Renouf; Khin Thway; Amen Sibtain; Iain A McNeish; Kate L Newbold; Howard Goldsweig; Robert Coffin; Christopher M Nutting
Journal: Clin Cancer Res Date: 2010-08-01 Impact factor: 12.531

Review 4. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases.

Authors: Peter Carmeliet; Rakesh K Jain
Journal: Nat Rev Drug Discov Date: 2011-06 Impact factor: 84.694

5. Global cancer statistics.

Authors: Ahmedin Jemal; Freddie Bray; Melissa M Center; Jacques Ferlay; Elizabeth Ward; David Forman
Journal: CA Cancer J Clin Date: 2011-02-04 Impact factor: 508.702

Review 6. Oncolytic viruses.

Authors: E Antonio Chiocca
Journal: Nat Rev Cancer Date: 2002-12 Impact factor: 60.716

Review 7. Targeted therapies for hepatocellular carcinoma.

Authors: Augusto Villanueva; Josep M Llovet
Journal: Gastroenterology Date: 2011-03-13 Impact factor: 22.682

8. Phase II clinical trial of a granulocyte-macrophage colony-stimulating factor-encoding, second-generation oncolytic herpesvirus in patients with unresectable metastatic melanoma.

Authors: Neil N Senzer; Howard L Kaufman; Thomas Amatruda; Mike Nemunaitis; Tony Reid; Gregory Daniels; Rene Gonzalez; John Glaspy; Eric Whitman; Kevin Harrington; Howard Goldsweig; Tracey Marshall; Colin Love; Robert Coffin; John J Nemunaitis
Journal: J Clin Oncol Date: 2009-11-02 Impact factor: 44.544

9. Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

Authors: Byeong-Ho Park; Taeho Hwang; Ta-Chiang Liu; Daniel Y Sze; Jae-Seok Kim; Hyuk-Chan Kwon; Sung Yong Oh; Sang-Young Han; Jin-Han Yoon; Sook-Hee Hong; Anne Moon; Kelly Speth; Chohee Park; Young-Joo Ahn; Manijeh Daneshmand; Byung Geon Rhee; Herbert M Pinedo; John C Bell; David H Kirn
Journal: Lancet Oncol Date: 2008-05-19 Impact factor: 41.316

10. Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer.

Authors: Jeong Heo; Tony Reid; Leyo Ruo; Caroline J Breitbach; Steven Rose; Mark Bloomston; Mong Cho; Ho Yeong Lim; Hyun Cheol Chung; Chang Won Kim; James Burke; Riccardo Lencioni; Theresa Hickman; Anne Moon; Yeon Sook Lee; Mi Kyeong Kim; Manijeh Daneshmand; Kara Dubois; Lara Longpre; Minhtran Ngo; Cliona Rooney; John C Bell; Byung-Geon Rhee; Richard Patt; Tae-Ho Hwang; David H Kirn
Journal: Nat Med Date: 2013-02-10 Impact factor: 53.440